200 related articles for article (PubMed ID: 34696508)
1. The Expression Level of HIV-1 Vif Is Optimized by Nucleotide Changes in the Genomic SA1D2prox Region during the Viral Adaptation Process.
Koma T; Doi N; Takemoto M; Watanabe K; Yamamoto H; Nakashima S; Adachi A; Nomaguchi M
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696508
[TBL] [Abstract][Full Text] [Related]
2. Natural Single-Nucleotide Variations in the HIV-1 Genomic SA1prox Region Can Alter Viral Replication Ability by Regulating Vif Expression Levels.
Nomaguchi M; Doi N; Sakai Y; Ode H; Iwatani Y; Ueno T; Matsumoto Y; Miyazaki Y; Masuda T; Adachi A
J Virol; 2016 May; 90(9):4563-4578. PubMed ID: 26912631
[TBL] [Abstract][Full Text] [Related]
3. Expression Level of HIV-1 Vif Can Be Fluctuated by Natural Nucleotide Variations in the
Doi N; Koma T; Adachi A; Nomaguchi M
Front Microbiol; 2019; 10():2758. PubMed ID: 31849897
[TBL] [Abstract][Full Text] [Related]
4. Production of HIV-1
Nomaguchi M; Doi N; Yoshida T; Koma T; Adachi S; Ode H; Iwatani Y; Yokoyama M; Sato H; Adachi A
Front Microbiol; 2017; 8():2542. PubMed ID: 29326677
[TBL] [Abstract][Full Text] [Related]
5. Regulation of Vif mRNA splicing by human immunodeficiency virus type 1 requires 5' splice site D2 and an exonic splicing enhancer to counteract cellular restriction factor APOBEC3G.
Mandal D; Exline CM; Feng Z; Stoltzfus CM
J Virol; 2009 Jun; 83(12):6067-78. PubMed ID: 19357165
[TBL] [Abstract][Full Text] [Related]
6. Long-term passage of Vif-null HIV-1 in CD4
Miyagi E; Kao S; Fumitaka M; Buckler-White A; Plishka R; Strebel K
Virology; 2017 Apr; 504():1-11. PubMed ID: 28131088
[TBL] [Abstract][Full Text] [Related]
7. Natural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivity.
Refsland EW; Hultquist JF; Luengas EM; Ikeda T; Shaban NM; Law EK; Brown WL; Reilly C; Emerman M; Harris RS
PLoS Genet; 2014 Nov; 10(11):e1004761. PubMed ID: 25411794
[TBL] [Abstract][Full Text] [Related]
8. HIV-1 Vif adaptation to human APOBEC3H haplotypes.
Ooms M; Brayton B; Letko M; Maio SM; Pilcher CD; Hecht FM; Barbour JD; Simon V
Cell Host Microbe; 2013 Oct; 14(4):411-21. PubMed ID: 24139399
[TBL] [Abstract][Full Text] [Related]
9. A naturally occurring Vif mutant (I107T) attenuates anti-APOBEC3G activity and HIV-1 replication.
Peng J; Ao Z; Matthews C; Wang X; Ramdahin S; Chen X; Li J; Chen L; He J; Ball B; Fowke K; Plummer F; Embree J; Yao X
J Mol Biol; 2013 Aug; 425(16):2840-52. PubMed ID: 23707381
[TBL] [Abstract][Full Text] [Related]
10. An intronic G run within HIV-1 intron 2 is critical for splicing regulation of vif mRNA.
Widera M; Erkelenz S; Hillebrand F; Krikoni A; Widera D; Kaisers W; Deenen R; Gombert M; Dellen R; Pfeiffer T; Kaltschmidt B; Münk C; Bosch V; Köhrer K; Schaal H
J Virol; 2013 Mar; 87(5):2707-20. PubMed ID: 23255806
[TBL] [Abstract][Full Text] [Related]
11. Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression.
Exline CM; Feng Z; Stoltzfus CM
J Virol; 2008 Apr; 82(8):3921-31. PubMed ID: 18272582
[TBL] [Abstract][Full Text] [Related]
12. Analysis of Competing HIV-1 Splice Donor Sites Uncovers a Tight Cluster of Splicing Regulatory Elements within Exon 2/2b.
Brillen AL; Walotka L; Hillebrand F; Müller L; Widera M; Theiss S; Schaal H
J Virol; 2017 Jul; 91(14):. PubMed ID: 28446664
[TBL] [Abstract][Full Text] [Related]
13. A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.
Duan S; Wang S; Song Y; Gao N; Meng L; Gai Y; Zhang Y; Wang S; Wang C; Yu B; Wu J; Yu X
J Biol Chem; 2020 Oct; 295(43):14592-14605. PubMed ID: 32817167
[TBL] [Abstract][Full Text] [Related]
14. APOBEC3H haplotypes and HIV-1 pro-viral vif DNA sequence diversity in early untreated human immunodeficiency virus-1 infection.
Gourraud PA; Karaouni A; Woo JM; Schmidt T; Oksenberg JR; Hecht FM; Liegler TJ; Barbour JD
Hum Immunol; 2011 Mar; 72(3):207-12. PubMed ID: 21167246
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 adaptation studies reveal a novel Env-mediated homeostasis mechanism for evading lethal hypermutation by APOBEC3G.
Ikeda T; Symeonides M; Albin JS; Li M; Thali M; Harris RS
PLoS Pathog; 2018 Apr; 14(4):e1007010. PubMed ID: 29677220
[TBL] [Abstract][Full Text] [Related]
16. Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif function.
Albin JS; Haché G; Hultquist JF; Brown WL; Harris RS
J Virol; 2010 Oct; 84(19):10209-19. PubMed ID: 20686027
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
[TBL] [Abstract][Full Text] [Related]
18. Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.
Desimmie BA; Delviks-Frankenberrry KA; Burdick RC; Qi D; Izumi T; Pathak VK
J Mol Biol; 2014 Mar; 426(6):1220-45. PubMed ID: 24189052
[TBL] [Abstract][Full Text] [Related]
19. HIV restriction by APOBEC3 in humanized mice.
Krisko JF; Martinez-Torres F; Foster JL; Garcia JV
PLoS Pathog; 2013 Mar; 9(3):e1003242. PubMed ID: 23555255
[TBL] [Abstract][Full Text] [Related]
20. Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection.
Kim EY; Lorenzo-Redondo R; Little SJ; Chung YS; Phalora PK; Maljkovic Berry I; Archer J; Penugonda S; Fischer W; Richman DD; Bhattacharya T; Malim MH; Wolinsky SM
PLoS Pathog; 2014 Jul; 10(7):e1004281. PubMed ID: 25080100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
